AVEO Oncology
AVEO
#7117
Rank
A$0.73 B
Marketcap
A$21.07
Share price
0.00%
Change (1 day)
136.61%
Change (1 year)

AVEO Oncology (AVEO) - Total debt

Total debt on the balance sheet as of September 2022 : A$54.33 Million

According to AVEO Oncology 's latest financial reports the company's total debt is A$54.33 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

AVEO Oncology - Total debt on balance sheet (from 2008 to 2022)

Total debt by year

Year Total debt Change
2021-12-31A$52.37 M178.18%
2020-12-31A$18.82 M-16.39%
2019-12-31A$22.51 M-16.65%
2018-12-31A$27.01 M14.16%
2017-12-31A$23.66 M21.83%
2016-12-31A$19.42 M49.42%
2015-12-31A$13 M-48.48%
2014-12-31A$25.23 M17.2%
2013-12-31A$21.53 M-14.07%
2012-12-31A$25.05 M6.29%
2011-12-31A$23.57 M2.32%
2010-12-31A$23.03 M4.82%
2009-12-31A$21.97 M-26.35%
2008-12-31A$29.84 M73.05%
2007-12-31A$17.24 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eli Lilly
LLY
A$59.70 B 109,783.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$76.68 B 141,024.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$9.23 B 16,904.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$3.80 B 6,895.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$66.22 B 121,769.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
A$23.31 M-57.09%๐Ÿ‡บ๐Ÿ‡ธ USA